Elmwood Park, NJ, United States of America

Barbara E Kurys


Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 82(Granted Patents)


Location History:

  • Morris Plains, NJ (US) (1990)
  • Elmwood Park, NJ (US) (1990 - 1998)
  • Loveland, OH (US) (1997 - 1999)
  • Long Valley, NJ (US) (1999)

Company Filing History:


Years Active: 1990-1999

Loading Chart...
17 patents (USPTO):

Title: The Innovative Contributions of Barbara E. Kurys

Introduction

Barbara E. Kurys is a notable inventor based in Elmwood Park, NJ (US), recognized for her significant contributions to the field of pharmaceuticals. With a total of 17 patents to her name, she has made remarkable advancements in the development of compounds aimed at treating memory dysfunction and depression.

Latest Patents

Among her latest patents are the N-(pyridinylamino) isoindolines and related compounds. This patent discloses novel N-(pyridinylamino) isoindolines, intermediates, and processes for their preparation. It also outlines methods for relieving memory dysfunction and treating depression using these compounds. Another significant patent involves pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles. This patent details novel compounds, intermediates, and processes for their preparation, along with methods for addressing memory dysfunction and depression.

Career Highlights

Barbara has worked with prominent companies such as Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel. Her work in these organizations has contributed to her extensive knowledge and expertise in pharmaceutical innovations.

Collaborations

Throughout her career, Barbara has collaborated with esteemed colleagues, including Edward J. Glamkowski and David M. Fink. These partnerships have further enriched her research and development efforts.

Conclusion

Barbara E. Kurys stands out as a pioneering inventor whose work has the potential to impact the treatment of memory dysfunction and depression significantly. Her innovative spirit and dedication to research continue to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…